Spermidine alleviates experimental autoimmune encephalomyelitis through inducing inhibitory macrophages

Cell Death and Differentiation

Volumn 23, Issue 11, 2016, Pages 1850-1861

  Yang, Q ^a   Zheng, C ^a   Cao, J ^a   Cao, G ^a   Shou, P ^a   Lin, L ^a   Velletri, T ^a   Jiang, M ^a   Chen, Q ^a   Han, Y ^a   Li, F ^a   Wang, Y ^a   Cao, W ^a   Shi, Y ^a,b,c  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

^c CHILD HEALTH INSTITUTE OF NEW JERSEY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGINASE 1; B7 ANTIGEN; CD4 ANTIGEN; INTERLEUKIN 12; INTERLEUKIN 1BETA; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; SPERMIDINE; ARGINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4+ T LYMPHOCYTE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DISEASE COURSE; DRUG EFFECT; EX VIVO STUDY; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; IMMUNOREGULATION; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; ADOPTIVE TRANSFER; ANIMAL; BIOLOGICAL MODEL; C57BL MOUSE; CELL POLARITY; DRUG EFFECTS; IMMUNOLOGY; IMMUNOSUPPRESSIVE TREATMENT; LEUKOCYTE; METABOLISM; PATHOLOGY; PHENOTYPE; SIGNAL TRANSDUCTION;

ADOPTIVE TRANSFER; ANIMALS; ARGINASE; CELL POLARITY; CENTRAL NERVOUS SYSTEM; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; IMMUNOSUPPRESSION; LEUKOCYTES; MACROPHAGES; MICE, INBRED C57BL; MODELS, BIOLOGICAL; NF-KAPPA B; PHENOTYPE; SIGNAL TRANSDUCTION; SPERMIDINE;

EID: 84979300851     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/cdd.2016.71     Document Type: Article

References (44)

1. Bar-Or A. Immunology of multiple sclerosis. Neurol Clin 2005; 23: 149-175.
2. Steinman L. Immunology of relapse and remission in multiple sclerosis. Annu Rev Immunol 2014; 32: 257-281.
3. Franklin RJM, Ffrench-Constant C. Remyelination in the CNS: from biology to therapy. Nat Rev Neurosci 2008; 9: 839-855.
4. Inoue M, Shinohara ML. The role of interferon-beta in the treatment of multiple sclerosis and experimental autoimmune encephalomyelitis - in the perspective of inflammasomes. Immunology 2013; 139: 11-18.
5. Malpass K. Disease mechanisms in MS: a role for sodium channels in regulation of macrophage-mediated pathology in multiple sclerosis lesions. Nat Rev Neurol 2012; 8: 592.
6. Bogie JF, Stinissen P, Hendriks JJ. Macrophage subsets and microglia in multiple sclerosis. Acta Neuropathol 2014; 128: 191-213.
7. Bauer J, Berkenbosch F, Van Dam AM, Dijkstra CD. Demonstration of interleukin-1 beta in Lewis rat brain during experimental allergic encephalomyelitis by immunocytochemistry at the light and ultrastructural level. J Neuroimmunol 1993; 48: 13-21.
8. Villarroya H, Marie Y, Ouallet JC, Le Saux F, Tchelingerian JL, Baumann N. Expression of TNF alpha in central neurons of Lewis rat spinal cord after EAE induction. J Neurosci Res 1997; 49: 592-599.
9. Okuda Y, Nakatsuji Y, Fujimura H, Esumi H, Ogura T, Yanagihara T, et al. Expression of the inducible isoform of nitric oxide synthase in the central nervous system of mice correlates with the severity of actively induced experimental allergic encephalomyelitis. J Neuroimmunol 1995; 62: 103-112.
10. Anthony DC, Miller KM, Fearn S, Townsend MJ, Opdenakker G, Wells GM, et al. Matrix metalloproteinase expression in an experimentally-induced DTH model of multiple sclerosis in the rat CNS. J Neuroimmunol 1998; 87: 62-72.
11. Raine CS. Analysis of autoimmune demyelination - its impact upon multiple-sclerosis. Lab Invest 1984; 50: 608-635.
12. Huitinga I, Vanrooijen N, Degroot CJA, Uitdehaag BMJ, Dijkstra CD. Suppression of experimental allergic encephalomyelitis in Lewis rats after elimination of macrophages. J Exp Med 1990; 172: 1025-1033.
13. Gordon S, Martinez FO. Alternative activation of macrophages: mechanism and functions. Immunity 2010; 32: 593-604.
14. Rodriguez PC, Quiceno DG, Zabaleta J, Ortiz B, Zea AH, Piazuelo MB, et al. Arginase I production in the tumor microenvironment by mature myeloid cells inhibits T-cell receptor expression and antigen-specific T-cell responses. Cancer Res 2004; 64: 5839-5849.
15. Iarashi K, Kashiwagi K. Modulation of cellular function by polyamines. Int J Biochem Cell Biol 2010; 42: 39-51.
16. Merentie M, Uimari A, Pietila M, Sinervirta R, Keinanen TA, Vepsalainen J, et al. Oxidative stress and inflammation in the pathogenesis of activated polyamine catabolism-induced acute pancreatitis. Amino Acids 2007; 33: 323-330.
17. Thomas TJ, Gunnia UB, Seibold JR, Thomas T. Defective signal-transduction pathways in T-cells from autoimmune Mrl-Lpr/Lpr mice are associated with increased polyamine concentrations. Biochem J 1995; 311: 175-182.
18. Choi YH, Park HY. Anti-inflammatory effects of spermidine in lipopolysaccharide-stimulated BV2 microglial cells. J Biomed Sci 2012; 19: 31.
19. Zhu S, Ashok M, Li JH, Li W, Yang H, Wang P, et al. Spermine protects mice against lethal sepsis partly by attenuating surrogate inflammatory markers. Mol Med 2009; 15: 275-282.
20. Franca-Costa J, Van Weyenbergh J, Boaventura VS, Luz NF, Malta-Santos H, Oliveira MC, et al. Arginase I, polyamine, and prostaglandin E2 pathways suppress the inflammatory response and contribute to diffuse cutaneous leishmaniasis. J Infect Dis 2015; 211: 426-435.
21. Weiss TS, Herfarth H, Obermeier F, Ouart J, Vogl D, Scholmerich J, et al. Intracellular polyamine levels of intestinal epithelial cells in inflammatory bowel disease. Inflamm Bowel Dis 2004; 10: 529-535.
22. Jones MV, Nguyen TT, Deboy CA, Griffin JW, Whartenby KA, Kerr DA, et al. Behavioral and pathological outcomes in MOG 35-55 experimental autoimmune encephalomyelitis. J Neuroimmunol 2008; 199: 83-93.
23. Huitinga I, van Rooijen N, de Groot CJ, Uitdehaag BM, Dijkstra CD. Suppression of experimental allergic encephalomyelitis in Lewis rats after elimination of macrophages. J Exp Med 1990; 172: 1025-1033.
24. Gordon S, Taylor PR. Monocyte and macrophage heterogeneity. Nat Rev Immunol 2005; 5: 953-964.
25. Hayden MS, Ghosh S. NF-kappaB in immunobiology. Cell Res 2011; 21: 223-244.
26. Zou GM, Hu WY. LIGHT regulates CD86 expression on dendritic cells through NF-kappaB, but not JNK/AP-1 signal transduction pathway. J Cell Physiol 2005; 205: 437-443.
27. Zhao JL, Freeman GJ, Gray GS, Nadler LM, Glimcher LH. A cell type-specific enhancer in the human B7.1 gene regulated by NF-kappa B. J Exp Med 1996; 183: 777-789.
28. Rodriguez PC, Zea AH, DeSalvo J, Culotta KS, Zabaleta J, Quiceno DG, et al. L-arginine consumption by macrophages modulates the expression of CD3 zeta chain in T lymphocytes. J Immunol 2003; 171: 1232-1239.
29. Sahin E, Haubenwallner S, Kuttke M, Kollmann I, Halfmann A, Dohnal AM, et al. Macrophage PTEN regulates expression and secretion of arginase I modulating innate and adaptive immune responses. J Immunol 2014; 193: 1717-1727.
30. Newman TA, Woolley ST, Hughes PM, Sibson NR, Anthony DC, Perry VH. T-cell- and macrophage-mediated axon damage in the absence of a CNS-specific immune response: involvement of metalloproteinases. Brain 2001; 124(Pt 11): 2203-2214.
31. Rawji KS, Yong VW. The benefits and detriments of macrophages/microglia in models of multiple sclerosis. Clin Dev Immunol 2013; 2013: 948976.
32. Hilliard B, Samoilova EB, Liu TS, Rostami A, Chen Y. Experimental autoimmune encephalomyelitis in NF-kappa B-deficient mice:roles of NF-kappa B in the activation and differentiation of autoreactive T cells. J Immunol 1999; 163: 2937-2943.
33. Qiu F, Huang J, Sui M. Targeting arginine metabolism pathway to treat arginine-dependent cancers. Cancer Lett 2015; 364: 1-7.
34. Burrack KS, Tan JJ, McCarthy MK, Her Z, Berger JN, Ng LF, et al. Myeloid cell Arg1 inhibits control of arthritogenic alphavirus infection by suppressing antiviral T cells. PLoS Pathog 2015; 11: e1005191.
35. Shearer JD, Richards JR, Mills CD, Caldwell MD. Differential regulation of macrophage arginine metabolism: a proposed role in wound healing. Am J Physiol 1997; 272(2 Pt 1): E181-E190.
36. Rodriguez PC, Zea AH, Culotta KS, Zabaleta J, Ochoa JB, Ochoa AC. Regulation of T cell receptor CD3zeta chain expression by L-arginine. J Biol Chem 2002; 277: 21123-21129.
37. Gerner EW, Meyskens FL Jr. Polyamines and cancer: old molecules, new understanding. Nat Rev Cancer 2004; 4: 781-792.
38. Minois N, Carmona-Gutierrez D, Madeo F. Polyamines in aging and disease. Aging 2011; 3: 716-732.
39. Igarashi K, Kashiwagi K. Characteristics of cellular polyamine transport in prokaryotes and eukaryotes. Plant Physiol Biochem 2010; 48: 506-512.
40. Guo X, Harada C, Namekata K, Kimura A, Mitamura Y, Yoshida H, et al. Spermidine alleviates severity of murine experimental autoimmune encephalomyelitis. Invest Ophthalmol Vis Sci 2011; 52: 2696-2703.
41. Panagiotidis CA, Artandi S, Calame K, Silverstein SJ. Polyamines alter sequence-specific DNA-protein interactions. Nucleic Acids Res 1995; 23: 1800-1809.
42. Williams K. Interactions of polyamines with ion channels. Biochem J 1997; 325(Pt 2): 289-297.
43. Landau G, Bercovich Z, Park MH, Kahana C. The role of polyamines in supporting growth of mammalian cells is mediated through their requirement for translation initiation and elongation. J Biol Chem 2010; 285: 12474-12481.
44. Stromnes IM, Goverman JM. Active induction of experimental allergic encephalomyelitis. Nat Protoc 2006; 1: 1810-1819.